Original language | English (US) |
---|---|
Pages (from-to) | 1041-1043 |
Number of pages | 3 |
Journal | JAMA dermatology |
Volume | 159 |
Issue number | 10 |
DOIs |
|
State | Published - Oct 18 2023 |
Funding
Conflict of Interest Disclosures: All authors are editors of JAMA Network journals. Dr Galbraith reported research funding outside the submitted work. Dr Ayanian reported grants from National Institute on Aging, Michigan Department of Health and Human Services, and Merck Foundation; personal fees from Harvard University, University of Massachusetts Medical School, University of California San Diego, and Emory University; nonfinancial support from American Statistical Association, AcademyHealth, and National Academy of Medicine outside the submitted work; and serving on the board of directors of the Physicians Health Plan representing the University of Michigan. Dr Bressler reported grants to Johns Hopkins University from Bayer, Biogen, Boerhinger-Ingelheim, Genentech/Roche, Regeneron, and Samsung Bioepis; and personal fees from FDA for serving as chair of FDA Ophthalmic Devices Panel and from Emmes for serving as chair of National Eye Institute Data and Safety Monitoring Committee for Intramural Trials. Dr Disis reported Epithany Founder shares and grants from Precigen, Bavarian Nordisk, Veanna, and Aston Sci outside the submitted work. Dr Öngür reported personal fees from Neumora Inc and Guggenheim LLC and personal fees from Milken Institute for philanthropy outside the submitted work. Dr Piccirillo reported receiving royalty payments for the Sino-Nasal Outcome Test, SNORE-25, and NOSE HHT licensed by Washington University. No other disclosures were reported.
ASJC Scopus subject areas
- Dermatology